Mckinley Capital Management LLC Edwards Lifesciences Corp Transaction History

Mckinley Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $1.53 Million - $2.06 Million	-22,020 Reduced 48.78%	23,120 $1.6 Million
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $1.04 Million - $1.21 Million	12,820 Added 39.67%	45,140 $4.26 Million
Q4 2022 Jan 18, 2023	SELL	$68.3 - $87.44 $952,102 - $1.22 Million	-13,940 Reduced 30.13%	32,320 $0
Q2 2022 Aug 05, 2022	BUY	$86.5 - $128.27 $2.01 Million - $2.98 Million	23,250 Added 101.04%	46,260 $4.4 Million
Q1 2022 Apr 29, 2022	BUY	$101.96 - $128.34 $2.35 Million - $2.95 Million	23,010 New	23,010 $2.71 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.